Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma
NCT06864221
·
clinicaltrials.gov ↗
RECRUITING
Status
260
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Radiotherapy
Treatment Outcome
Biomarkers
Sphingolipids
Sponsor
Nanfang Hospital, Southern Medical University